Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain serotonin 5-HT1A receptor binding in mesial temporal lobe epilepsy using [11C]WAY-100635 PET
2004-004156-39Phase 3Completed
- Sponsor
- Department of Neurology, Medical University of Vienna
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of WAY-100635 in mesial temporal lobe epilepsy (MTLE), sponsored by Department of Neurology, Medical University of Vienna. Started Oct 2005; status: completed.
02
Drugs
WAY-100635
03
Conditions
mesial temporal lobe epilepsy (MTLE)
Beyond the preview
Go deeper on 2004-004156-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004156-39.